S-nitrosoglutathione prevents experimental cerebral malaria

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 2, 2012, Pages 477-487

  Zanini, Graziela M ^a,b   Martins, Yuri C ^a,c   Cabrales, Pedro ^a,d   Frangos, John A ^a   Carvalho, Leonardo J M ^a,e  

^a LA JOLLA BIOENGINEERING INSTITUTE   (United States)

^b Funda??o Oswaldo Cruz   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Cerebral malaria; Nitric oxide; Plasmodium berghei; S nitrosoglutathione

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; S NITROSOGLUTATHIONE; SODIUM CHLORIDE; NITRIC OXIDE DONOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN MALARIA; CELLULAR PARAMETERS; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SAFETY; EXPERIMENTAL CEREBRAL MALARIA; HEART RATE; HYPOTENSION; LEUKOCYTE ACCUMULATION; LOCOMOTION; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; ANIMAL; BLOOD PRESSURE; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; MALARIA; METABOLISM; PATHOLOGY; PLASMODIUM BERGHEI;

ANIMALS; BLOOD PRESSURE; BRAIN; DISEASE MODELS, ANIMAL; GLUTATHIONE; HEART RATE; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE DONORS; PLASMODIUM BERGHEI; S-NITROSOGLUTATHIONE;

EID: 84866500044     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9343-6     Document Type: Article

References (34)

1. Aoyama K, Watabe M, Nakaki T (2008) Regulation of neuronal glutathione synthesis. J Pharmacol Sci 108(3):227-238
2. Astrand A, Bohlooly YM, Larsdotter S, Mahlapuu M, Andersen H, Tornell J, Ohlsson C, Snaith M, Morgan DG (2004) Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. Am J Physiol Regul Integr Comp Physiol 287(4):R749-R758. doi:10.1152/ajpregu.00134.2004 (Pubitemid 39280459)
3. Bauer PR, Van Der Heyde HC, Sun G, Specian RD, Granger DN (2002) Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 9(6):463-470. doi:10.1038/sj.mn. 7800159 (Pubitemid 135684856)
4. Beare NA, Harding SP, Taylor TE, Lewallen S, Molyneux ME (2009) Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis 199(2):263-271. doi:10.1086/595735
5. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ (2010) Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol 176(3):1306-1315. doi:10.2353/ajpath.2010.090691
6. Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ (2011) Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J Infect Dis 203(10):1454-1463. doi:10.1093/infdis/jir058
7. Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreira-da-Cruz MF (2000) Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol 95(1):1-7. doi:10.1006/expr.2000.4508 (Pubitemid 30415947)
8. Chiueh CC, Rauhala P (1999) The redox pathway of Snitrosoglutathione, glutathione and nitric oxide in cell to neuron communications. Free Radic Res 31(6):641-650
9. Clemmer L, Martins YC, Zanini GM, Frangos JA, Carvalho LJ (2011) Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain. Antimicrob Agents Chemother 55 (4):1383-1390. doi:10.1128/AAC.01277-10
10. Cornford EM, Braun LD, Crane PD, Oldendorf WH (1978) Bloodbrain barrier restriction of peptides and the low uptake of enkephalins. Endocrinology 103(4):1297-1303 (Pubitemid 9059227)
11. Foster MW, Hess DT, Stamler JS (2009) Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med 15 (9):391-404. doi:10.1016/j.molmed.2009.06.007
12. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, Intaglietta M, van der Heyde HC (2006) Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 12(12):1417-1422. doi:10.1038/nm1499 (Pubitemid 44924501)
13. Haq E, Rohrer B, Nath N, Crosson CE, Singh I (2007) Snitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis. J Ocul Pharmacol Ther 23(3):221-231. doi:10.1089/jop.2007.0023 (Pubitemid 46986602)
14. John CC, Kutamba E, Mugarura K, Opoka RO (2010) Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther 8(9):997-1008. doi:10.1586/eri.10.90
15. Khan M, Sekhon B, Giri S, Jatana M, Gilg AG, Ayasolla K, Elango C, Singh AK, Singh I (2005) S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab 25 (2):177-192. doi:10.1038/sj.jcbfm.9600012 (Pubitemid 40171200)
16. Khan M, Jatana M, Elango C, Paintlia AS, Singh AK, Singh I (2006) Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15(2):114-124. doi:10.1016/j.niox.2006.01.008 (Pubitemid 44175884)
17. Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, Tannich E, Schmutzhard E (2006) Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol 32(2):177-188. doi:10.1111/j.1365- 2990.2006.00706.x
18. Martins YC, Werneck GL, Carvalho LJ, Silva BP, Andrade BG, Souza TM, Souza DO, Daniel-Ribeiro CT (2010) Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol. Malar J 9:85. doi:10.1186/1475-2875-9- 85
19. Martins YC, Zanini GM, Frangos JA, Carvalho LJ. Efficacy of different nitric oxide-based strategies in preventing experimental cerebral malaria by Plasmodium berghei ANKA. PLoS One (in press)
20. Nath N, Morinaga O, Singh I (2010) S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol 5(2):240-251. doi:10.1007/s11481-009-9187-x
21. Patel RP, Hogg N, Spencer NY, Kalyanaraman B, Matalon S, Darley-Usmar VM (1999) Biochemical characterization of human S-nitrosohemoglobin. Effects on oxygen binding and transnitrosation. J Biol Chem 274(22):15487-15492
22. Peyrot F, Grillon C, Vergely C, Rochette L, Ducrocq C (2005) Pharmacokinetics of 1-nitrosomelatonin and detection by EPR using iron dithiocarbamate complex in mice. Biochem J 387(Pt 2):473-478. doi:10.1042/BJ20040828 (Pubitemid 40571234)
23. Radomski MW, Palmer RM, Moncada S (1987) Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92(1):181-187 (Pubitemid 17134934)
24. Radomski MW, Rees DD, Dutra A, Moncada S (1992) S-nitrosoglutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol 107(3):745-749
25. Rauhala P, Lin AM, Chiueh CC (1998) Neuroprotection by Snitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J 12(2):165-173 (Pubitemid 28080186)
26. Rockett KA, Awburn MM, Cowden WB, Clark IA (1991) Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 59(9):3280-3283
27. Singel DJ, Stamler JS (2005) Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and Snitrosohemoglobin. Annu Rev Physiol 67:99-145. doi:10.1146/annurev.physiol.67.060603.090918 (Pubitemid 40404487)
28. Singh SP,Wishnok JS, Keshive M, Deen WM, Tannenbaum SR (1996) The chemistry of the S-nitrosoglutathione/glutathione system. Proc Natl Acad Sci U S A 93(25):14428-14433 (Pubitemid 26418983)
29. Totino PR, Daniel-Ribeiro CT, Corte-Real S, de Fatima Ferreira-da-Cruz M (2008) Plasmodium falciparum: erythrocytic stages die by autophagic-like cell death under drug pressure. Exp Parasitol 118 (4):478-486. doi:10.1016/j.exppara. 2007.10.017
30. WHO (2010) World malaria report. WHO, Geneva
31. Wiese L, Kurtzhals JA, Penkowa M (2006) Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol 200(1):216-226. doi:10.1016/j.expneurol.2006.02.011 (Pubitemid 44097022)
32. Zanini GM, Cabrales P, Barkho W, Frangos JA, Carvalho LJ (2011) Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. J Neuroinflammation 8:66. doi:10.1186/1742-2094-8-66
33. Zeng H, Spencer NY, Hogg N (2001) Metabolism of S-nitrosoglutathione by endothelial cells. Am J Physiol Heart Circ Physiol 281(1):H432-H439
34. Zhang Y, Hogg N (2002) Mixing artifacts from the bolus addition of nitric oxide to oxymyoglobin: implications for S-nitrosothiol formation. Free Radic Biol Med 32(11):1212-1219 (Pubitemid 34603358)